在大鼠系统服药后,布梅他尼德在大脑中的异质分布
Wolfgang Löscher1,2,3, Martina Gramer2, Kerstin Römermann2
1Translational Neuropharmacology Laboratory, NIFE, Department of Experimental Otology of the ENT Clinics, Hannover Medical School, Hannover, Germany.
Biopharmaceutics & drug disposition
|June 1, 2024
概括
布米坦胺很难进入大脑,所有区域的水平都低于大脑的水平.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 布米坦胺抑制了Na-K-2Cl共运输体 (NKCC1) 以使神经内化物水平正常化.
- 系统性布梅坦尼德由于电离,蛋白质结合和排泄运输,无法透到大脑.
- 之前的研究缺乏对布梅他尼德大脑分布的区域分析.
研究的目的:
- 为了量化14个不同的老鼠大脑区域中的bumetanide水平.
- 为了确定布米胺度的区域差异是否可以解释其对大脑疾病的影响.
- 评估布梅坦尼德能否达到特定脑部区域NKCC1抑制的治疗度.
主要方法:
- 鼠在皮佩罗尼尔丁氧化物预处理后接受静脉注射布梅他尼德 (10毫克/公斤),以减少新陈代谢.
- 用经过验证的分析方法,在14个大脑区域测量了布梅坦尼德度.
- 分析了区域大脑:血比率和与大脑血流的相关性.
主要成果:
- 观察到布梅他尼德水平的区域差异很大,其中中脑和嗅觉球泡的度最高.
- 大脑:血比率从0.004 (杏仁体) 到0.022 (嗅觉球体) 不同.
- 在所有分析的大脑区域,区域性布米坦胺水平低于NKCC1抑制的IC50.
结论:
- 在老鼠大脑中的区域布梅坦胺分布是异质的.
- 在所有大脑区域观察到的布梅他尼德水平不足以有效抑制NKCC1.
- 在动物大脑疾病模型中,布米坦胺的治疗效果不太可能由NKCC1抑制介导.
相关概念视频
01:20Compartment Models: Two-Compartment Model
5.4K
The two-compartment model divides the body into central and peripheral compartments to account for varying blood perfusion rates among organs and tissues, affecting drug distribution. The central compartment includes blood and highly perfused tissues with rapid drug distribution, while the peripheral compartment contains tissues with slower drug distribution. After a single IV bolus dose, the drug concentration is high in plasma and low in tissues. The drug distribution between compartments...
5.4K
01:21Drug Distribution: Tissue Binding
2.6K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
2.6K
01:24Tissue-Drug Binding: Localization of Drugs and its Significance
79
Body tissues, comprising approximately 40% of the body weight, are crucial in drug distribution and localization. These tissues can serve as drug storage sites, competing with plasma binding sites for drug molecules.
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
79
01:30Factors Affecting Drug Distribution: Tissue Permeability
186
The drug distribution process within the human body is a complex interplay of various physicochemical properties inherent to the drugs. These properties, including molecular size, ionization degree, partition coefficient, and stereochemical nature, significantly impact how drugs permeate biological membranes to reach their target tissues.
Small molecules with a molecular weight below 500 to 600 Daltons can easily pass through the capillary membrane, gaining access to different tissues. Larger...
Small molecules with a molecular weight below 500 to 600 Daltons can easily pass through the capillary membrane, gaining access to different tissues. Larger...
186
01:23Factors Affecting Drug Distribution: Physiological Barriers
196
Drug distribution in the body is intricately regulated by various physiological barriers that control the passage of substances. These include the capillary endothelial barrier, the blood-brain, blood-cerebrospinal fluid, blood-placental, and blood-testis barriers.
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
196